Patents by Inventor Douglas O. Spry
Douglas O. Spry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 5393882Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.Type: GrantFiled: February 24, 1993Date of Patent: February 28, 1995Assignee: Eli Lilly and CompanyInventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
-
Patent number: 5239068Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.Type: GrantFiled: April 20, 1992Date of Patent: August 24, 1993Assignee: Eli Lilly and CompanyInventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
-
Patent number: 5142039Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.Type: GrantFiled: September 26, 1990Date of Patent: August 25, 1992Assignee: Eli Lilly and CompanyInventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
-
Patent number: 4983732Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with allyloxycarbonyl, t-butoxycarbonyl, naphthyloxycarbonyl, trichloroethyloxycarbonyl, p-nitrobenzyloxycarbonyl, benzhydryloxycarbonyl, p-methoxybenzyloxycarbonyl, or o-nitrobenzyloxycarbonyl.Type: GrantFiled: September 21, 1989Date of Patent: January 8, 1991Assignee: Eli Lilly and CompanyInventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
-
Patent number: 4604386Abstract: 3-(alkynylalkyloxy)cephalosporin antibiotics and the intermediates therefor are disclosed. Pharmaceutical compositions for the antibiotics are also disclosed.Type: GrantFiled: July 9, 1984Date of Patent: August 5, 1986Assignee: Eli Lilly and CompanyInventor: Douglas O. Spry
-
Patent number: 4565655Abstract: Fused 4,7-.beta.-lactam bicyclic antibacterials, namely 8-acylamino-4-anilino-9-oxo-6-thia-1,3-diazabicyclo[5.2.0]non-3-ene-2-carb oxylic acids, and the esters, salts and sulfoxides thereof, are provided. The compounds as esters are prepared by process comprising heating a 3-azido-3-cephem ester with aniline, a substituted aniline, or an N-(C.sub.1 -C.sub.3 alkyl) derivative thereof.Type: GrantFiled: September 28, 1983Date of Patent: January 21, 1986Assignee: Eli Lilly and CompanyInventor: Douglas O. Spry
-
Patent number: 4560749Abstract: 3-Azido-3-cephem esters are reacted with electron rich olefins, e.g., enamines and cyclic enol ethers, to provide C.sub.3 amidines and imidates having antibacterial activity in the free acid form. For example, 3-azido-3-cephem esters react with ethyl vinyl ether to provide 3-[1-(ethoxyethylidene)amino]-3-cephem esters. The latter are deesterified to provide the free acid antibacterials.Type: GrantFiled: November 18, 1983Date of Patent: December 24, 1985Assignee: Eli Lilly and CompanyInventor: Douglas O. Spry
-
Patent number: 4533497Abstract: N-ethylidene azetidinones are new antibiotic compounds. They are produced from the reaction of a Grignard reagent with a cephalosporin substituted at the 3 position with a chloro, oxy, amino or sulfide moieties.Type: GrantFiled: December 27, 1982Date of Patent: August 6, 1985Assignee: Eli Lilly and CompanyInventor: Douglas O. Spry
-
Patent number: 4521598Abstract: 7.beta.-Acylamino-3-azido-3-cephem-4-carboxylic acid esters are obtained with the corresponding 3-halo or 3-sulfonyloxy-3-cephem esters and an alkali metal azide. The 3-azido compounds as the free acids or salts are antibacterial agents while in esterified form react with alcohols and phenols to provide 2-alkoxy (or 2-phenoxy)-3amino-3-cephem esters and isomeric ring expanded 4,7-bicyclo .beta.-lactam compounds, namely [2R-(2.alpha.,7.alpha.,8.beta.)-4-alkoxy (or 4-phenoxy)-9-oxo-8-acylamino-6-thia-1,3-diazabicyclo[5.2.0]non-3-ene-2-car boxylic acids and esters and the corresponding 3-alkoxy (or 3-phenoxy) 1,4-diazabicyclo[5.2.0]non-3-ene-2-carboxylic acids and esters. These reaction products obtained with the azide possess antibacterial properties.Type: GrantFiled: September 28, 1983Date of Patent: June 4, 1985Assignee: Eli Lilly and CompanyInventors: Douglas O. Spry, Wayne A. Spitzer
-
Patent number: 4334063Abstract: 7-Acylamido-2-halomethylidene-3-methyl and 3-acetoxymethyl-3-cephem-4-carboxylic acids and esters are prepared via reaction of the corresponding 2-exomethylene-3-cephem ester sulfoxides with chloro (or bromo) dimethyliminium chlorides (or bromides). The 2-halomethylidene derivatives are useful as antimicrobial agents and intermediates to novel 2-acyloxymethylidene cephalosporins and to the known 2-aryl (or alkyl) mercaptomethylidene cephalosporins.Type: GrantFiled: March 30, 1981Date of Patent: June 8, 1982Assignee: Eli Lilly and CompanyInventor: Douglas O. Spry
-
Patent number: 4334064Abstract: 7-Acylamido-2-halomethylidene-3-methyl and 3-acetoxymethyl-3-cephem-4-carboxylic acids and esters are prepared via reaction of the corresponding 2-exomethylene-3-cephem ester sulfoxides with chloro (or bromo) dimethyliminium chlorides (or bromides). The 2-halomethylidene derivatives are useful as antimicrobial agents and intermediates to novel 2-acyloxy-methylidene cephalosporins and to the known 2-aryl (or alkyl) mercaptomethylidene cephalosporins.Type: GrantFiled: March 30, 1981Date of Patent: June 8, 1982Assignee: Eli Lilly and CompanyInventor: Douglas O. Spry
-
Patent number: 4299954Abstract: 7-Acylamino-2-halomethylidene-3-methyl and 3-acetoxymethyl-3-cephem-4-carboxylic acids and esters are prepared via reaction of the corresponding 2-exomethylene-3-cephem ester sulfoxides with chloro (or bromo) dimethyliminium chlorides (or bromides). The 2-halomethylidene derivatives are useful as antimicrobial agents and intermediates to novel 2-acyloxymethylidene cephalosporins and to the known 2-aryl (or alkyl) mercaptomethylidene cephalosporins.Type: GrantFiled: November 5, 1979Date of Patent: November 10, 1981Assignee: Eli Lilly and CompanyInventor: Douglas O. Spry
-
Patent number: 4133808Abstract: Ozonolysis of 3-bromomethyl-2-cephem-4-carboxylic acid esters provides 1-(1-protected carboxy-2-hydroxy-3-bromo-1-propenyl)-3-amido(or imido)-4-formylthio-azetidin-2-ones, useful as intermediates in the preparation of cephalosporin antibiotics.Type: GrantFiled: May 10, 1977Date of Patent: January 9, 1979Assignee: Eli Lilly and CompanyInventors: Robin D. G. Cooper, Douglas O. Spry
-
Patent number: 4115643Abstract: 7-Acylamido-3-hydroxy-3-cephem-4-carboxylic acid ester sulfoxides are chlorinated and reduced in a single step process with phosphorus trichloride in dimethylformamide to provide 7-acylamido-3-chloro-3-cephem-4-carboxylic acid ester sulfides.Type: GrantFiled: August 8, 1977Date of Patent: September 19, 1978Assignee: Eli Lilly and CompanyInventors: Stjepan Kukolja, Douglas O. Spry
-
Patent number: 4048157Abstract: Ozonolysis of 3-bromomethyl-2-cephem-4-carboxylic acid esters provides 1-(1-protected carboxy-2-hydroxy-3-bromo-1-propenyl)-3-amido(or imido)-4-formylthio-azetidin-2-ones, useful as intermediates in the preparation of cephalosporin antibiotics.Type: GrantFiled: October 29, 1975Date of Patent: September 13, 1977Assignee: Eli Lilly and CompanyInventors: Robin D. G. Cooper, Douglas O. Spry
-
Patent number: 4031084Abstract: 7-Acylamido-3-exomethylenecepham ester sulfoxides are reacted with ozone to provide the corresponding 3-hydroxy-3-cephem ester sulfoxides, intermediates for 3-methoxy and 3-halo substituted cephalosporin antibiotics; e.g., p-nitrobenzyl 7-phenoxyacetamido-3-exomethylenecepham-4-carboxylate-1-oxide provides the corresponding 3-hydroxy-3-cephem ester sulfoxide.Type: GrantFiled: October 23, 1975Date of Patent: June 21, 1977Assignee: Eli Lilly and CompanyInventors: Stjepan Kukolja, Douglas O. Spry
-
Patent number: 4012380Abstract: Intermediate C-3 1-hydroxyalkyl or 1-hydroxyarylalkyl cephems, prepared by reacting Grignard reagents at low temperature with 3-formyl-2-cephem compounds, are oxidized to the corresponding 7-acylamino-3-acyl-2(or 3)cephem-4-carboxylic acids and esters thereof, which are useful as antibiotics or as intermediates in preparing antibiotic substances.Type: GrantFiled: December 10, 1974Date of Patent: March 15, 1977Assignee: Eli Lilly and CompanyInventor: Douglas O. Spry
-
Patent number: 4001226Abstract: 7-Acylamino and 7-amino-3-(substituted)carbonylamino-3(or 2)-cephem-4-carboxylic acids and esters thereof, which are useful as antibiotics or as intermediates in preparing antibiotic substances respectively, are prepared from 7-acylamino-3-azidocarbonyl-2(or 3)-cephem-4-carboxylic acid esters via the corresponding thermally derived 3-isocyanatocephem derivatives.Type: GrantFiled: December 4, 1974Date of Patent: January 4, 1977Assignee: Eli Lilly and CompanyInventor: Douglas O. Spry
-
Patent number: 3953436Abstract: 7-Acylamino and 7-amino-3-carboxy-3-cephem-4-carboxylic acids and derivatives thereof, which are useful as antibiotics or as intermediates in preparing antibiotic substances, are prepared by an NBS oxidation of acetal derivatives of 3-formyl cephalosporins.Type: GrantFiled: April 19, 1974Date of Patent: April 27, 1976Assignee: Eli Lilly and CompanyInventor: Douglas O. Spry
-
Patent number: 3933806Abstract: 7-Acylamino-2-(substituted ethyl)-3-(substituted alkyl)-3-cephem-4-carboxylic acids and esters are prepared via carbanion addition to 2-methylene-3-cephem sulfoxides to provide antibiotic cephalosporin Michael adducts.Type: GrantFiled: July 17, 1973Date of Patent: January 20, 1976Assignee: Eli Lilly and CompanyInventor: Douglas O. Spry